(73) Eisai R&D Management Co., Ltd., Tokyo 112-8088, 6-10, Koishikawa 4-
chome, Bunkyo-ku (JP)
(54) MAKROLIDE MIT VEGF-TRANSKRIPTIONSHEMMENDER WIRKUNG
(72) Mizui, Yoshiharu, Tsukuba-shi Ibaraki 305-0051, 4-5-74, Ninomiya (JP)
(72) Sakai, Takashi, Tsukuba-shi Ibaraki 305-0035, 5-6-3, Matsushiro (JP)
(72) Yamamoto, Satoshi, Moriya-shi Ibaraki 302-0124, 3-9-7, Misono (JP)
(72) Komeda, Keisuke, Tsukuba-shi Ibaraki 305-0031, 602 107, 1-4-3, Azuma (JP)
(72) Fujita, Masanori, Ushiku-shi Ibaraki 300-1206, 128-3-6, Hitachinonishi (JP)
(72) Okuda, Akifumi, Tsukuba-shi Ibaraki 300-2635, c/o EISAI CO, LTD Tsukuba
Research Laboratories 1-3 Tokodai 5-chome, (JP)
(72) Kishi, Kumiko, Tsukuba-shi Ibaraki 300-2635, c/o EISAI CO, LTD Tsukuba
Research Laboratories 1-3 Tokodai 5-chome, (JP)
(72) Niijima, Jun, Tsukuba-shi Ibaraki 300-2635, c/o EISAI CO, LTD Tsukuba
Research Laboratories 1-3 Tokodai 5-chome, (JP)
(72) Nagai, Mitsuo, Tsukuba-shi Ibaraki 305-0035, 5-2-35, Matsushiro (JP)
(72) Okamoto, Kiyoshi, Ibaraki 300-2635, c/o EISAI CO., LTD. Tsukuba Research
Laboratories 1-3, Tokodai 5-chome, Tsukuba-shi (JP)
(72) Iwata, Masao, Ibaraki 300-2635, c/o EISAI CO., LTD. Tsukuba Research
Laboratories 1-3, Tokodai 5-chome, Tsukuba-shi (JP)
(72) Kotake, Yoshihiko, Tsuchiura-shi Ibaraki 300-0832, 39-13, Sakuragaokacho
(JP)
(72) Uenaka, Toshimitsu, Ibaraki 300-2635, c/o EISAI CO., LTD. Tsukuba
Research Laboratories 1-3, Tokodai 5-chome, Tsukuba-shi (JP)
(72) Asai, Naoki, Ibaraki 300-2635, c/o EISAI CO., LTD. Tsukuba Research
Laboratories 1-3, Tokodai 5-chome, Tsukuba-shi (JP)
(72) Matsufuji, Motoko, Komae-shi Tokyo 201-0005, 3-23-5, Iwadominami (JP)
(72) Sameshima, Tomohiro, Tokyo 140-0011, 1002, 5-14-7, Higashioi, Shinagawa-
ku (JP)
(72) Kawamura, Naoto, Yamato-shi Kanagawa 242-0007, 207, 6-2-1, Chuorinkan
(JP)
(72) Dobashi, Kazuyuki, Hadano-shi Kanagawa 257-0013, 5-204, 3-4-1,
Minamigaoka (JP)
(72) Nakashima, Takashi, Shizuoka 430-0803, 91-1-105 Uematsi-cho, Higashi-ku
Hamamatsu-shi (JP)
(72) Yoshida, Masashi, Tokyo 166-0003, PALSCOURT II-1103 1-16-21,
Koenjiminami, Suginami-ku (JP)
(72) Tsuchida, Toshio, Shizuoka 438-0077, Kosumosu 102 118-1, Kounodai,
Iwata-shi (JP)
(72) Takeda, Susumu, Shizuoka 438-0078, Hikari Haitsu-336 1797, Nakaizumi,
Iwata-shi (JP)
(72) Yamada, Tomonari, Shizuoka 426-0066, 1-16-8, Aoba-cho, Fujieda-shi (JP)
(72) Norihisa, Koji, Shizuoka 438-0078, HIKARI AHITSU-343 1797, Nakaizumi,
Iwata-shi (JP)
(72) Yamori, Takao, Tokyo 162-0836, 102, 34-2, Minamicho Shinjuku-ku (JP)
(30) JP 2001 02 01 2001025458
(73) Eli Lilly and Company, Indianapolis, IN 46285, Lilly Corporate Center (US)
(54) ANDROGENREZEPTORMODULATOR UND SEINE VERWENDUNG
(72) JADHAV, Prabhakar, Kondaji, Indianapolis, Indiana 46285, Eli Lilly and
Company Lilly Corporate Center (US)
(72) KRISHNAN, Venkatesh, Indianapolis, Indiana 46285, Eli Lilly and Company
Lilly Corporate Center (US)
(30) US 2009 11 13 261022 P
(73) Krka Tovarna Zdravil, D.D., Novo Mesto, 8501 Novo Mesto, Smarjeska cesta
6 (SI)
(54) VERFAHREN ZUR HERSTELLUNG EINES
OLMESARTANMEDOXOMILZWISCHENPRODUKTS
(72) ZUPANCIC, Silvo, 8000 Novo Mesto, Zupnca 4-b (SI)
(30) SI 2008 09 05 200800208
(73) Theravance, Inc., South San Francisco, CA 94080, 901 Gateway Boulevard
(US)
(54) HETEROARYLALKYL-8-AZABICYCLO[3.2.1]OKTAN-VERBINDUNGEN ALS
MU-OPIOID-REZEPTORANTAGONISTEN
(72) LONG, Daniel, D., San Francisco, CA 94114, 4358 23rd Street (US)
(72) JIANG, Lan, Foster City, CA 94404, 788 Santa Maria Lane (US)
(72) SAITO, Daisuke, Roland, Burlingame, CA 94010, 1515 Broadway Avenue Apt
1 (US)
(72) VAN DYKE, Priscilla, San Francisco, CA 94102, 550 Fell Street 5 (US)
(30) US 2007 08 27 966317 P
(73) Novartis AG, 4056 Basel, Lichtstrasse 35 (CH)
(54) KRISTALLINES MONOTOSYLAT-SALZ VON 2-METHYL-2-[4-(3-METHYL-2-
OXO-8-CHINOLIN-3-YL-2,3-DIHYDROIMIDAZO[4,5-C]CHINOLIN-1-YL)PHENYL]-
PROPIONITRIL
(72) STOWASSER, Frank, 79730 Murg, Wieladinger Strasse 3 (DE)
(72) BÄNZIGER, Markus, 4416 Bubendorf, Dahlienstrasse 27 (CH)
(72) GARAD, Sudhakar Devidasrao, Malden, Massachusetts 02148, 36 Jonathan
Lane (US)
(30) US 2006 11 20 866483 P
(73) Cancer Research Technology Limited, London EC1V 4AD, Angel Building 407
St John Street (GB)
(73) The Institute of Cancer Research: Royal Cancer Hospital, London SW7 3RP,
123 Old Brompton Road (GB)
(54) 1-(5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YL)-3-[2-FLUOR-4-(1-
METHYL-2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-7-YLOXY)-PHENYL]-
HARNSTOFF UND ASSOZIIERTE VERBINDUNGEN SOWIE IHRE VERWENDUNG
FÜR THERAPEUTISCHE ZWECKE
(72) SPRINGER, Caroline, Sutton, Surrey SM2 5NG, The Institute of Cancer
Research Cancer Research UK Center for Cancer Therapeutics 15 Costwold Road
(GB)
(72) NICULESCU-DUVAZ, Ion, Sutton, Surrey SM2 5NG, The Institute of Cancer
Research Cancer Research UK Center for Cancer Therapeutics 15 Costwold Road
(GB)
(72) MARAIS, Richard, London SW3 6JB, The Institute of Cancer Research
Section of Cell and Molecular Biology 237 Fulham Road (GB)
(72) NICULESCU-DUVAZ, Dan, Sutton, Surrey SM2 5NG, The Institute of Cancer
Research Cancer Research UK Center for Cancer Therapeutics 15 Costwold Road
(GB)
(72) ZAMBON, Alfonso, Sutton, Surrey SM2 5NG, The Institute of Cancer
Research Cancer Research UK Center for Cancer Therapeutics 15 Costwold Road
(GB)
(72) MENARD, Delphine, F-72700 Allonnes, 27 Rue Jules Massenet (FR)
(30) US 2010 02 01 300085 P
(73) Lorus Therapeutics Inc., Toronto, Ontario M9W 4Z7, 2 Meridian Road (CA)
(54) 2-INDOLYL IMIDAZO[4,5-D]PHENANTHROLIN DERIVATE UND DEREN
VERWENDUNG BEI DER BEHANDLUNG VON KREBS
(72) HUESCA, Mario, Toronto, Ontario M2M 3X7, 4001 Bayview Avenue Apt. 306
(CA)
(72) YOUNG, Aiping, H., Toronto, Ontario M3B 2B5, 7 Sandfield Road (CA)
(72) LEE, Yoon, Mississauga, Ontario L5A 2L7, 2219 Corsair Road (CA)
(72) KHINE, Aye Aye, Concord, Ontario L4K 3J7, 14 Marita Place (CA)
(72) WRIGHT, Jim, A., Oakville, Ontario L6L 5Z3, 44 Shore Gardens (CA)
(72) LOCK, Lisa, Toronto, Ontario M4E 2J7, 49 Devon Road (CA)
(72) Al-Qawasmeh, Raed., Amman 11942, University of Jordan Housing, Building
11, Apt 69 (JO)
(30) US 2005 05 25 684162 P
(30) US 2005 08 22 710551 P
(30) US 2006 03 31 787526 P
(73) Bristol-Myers Squibb Company, Princeton, NJ 08543-4000, Route 206 and
Province Line Road (US)
(54) PYRROLOTRIAZIN-KINASEINHIBITOREN
(72) FINK, Brian E., Princeton, New Jersey 08543, Bristol-Myers Squibb Co. Route
206 & Province Line Road (US)
(72) CHEN, Ping, Belle Mead, New Jersey 08502, 21 Derby Chase Court (US)
(30) US 2006 11 03 864175 P
(73) F. Hoffmann-La Roche AG, 4070 Basel, Grenzacherstrasse 124 (CH)
(54) PYRROLOPYRAZINYL-HARNSTOFF KINASE-INHIBITOREN
(72) BAMBERG, Joe Timothy, East Palo Alto California 94303, 787 Green Street
(US)
(72) HERMANN, Johannes Cornelius, Jersey City New Jersey 07307, 126
Webster 3C (US)
(72) LEMOINE, Remy, San Francisco California 94114, 1 Worth Street (US)
(72) SOTH, Michael, Glen Rock New Jersey 07452, 10 Hillview Terrace (US)
(30) US 2008 12 05 201008 P
(30) US 2009 09 21 244174 P
(73) Pfizer Inc., New York, NY 10017-5755, 235 East 42nd Street (US)
(54) PYRROLO[2,3-D]PYRIMIDINE
(72) XIE, Jin, Ballwin Missouri 63021, 423 Castle Pines Ct. (US)
(72) PROMO, Michele Ann, Chesterfield Missouri 63017, 14246 Reelfoot Lake Dr.
(US)
(72) JACOBSEN, Eric Jon, Chesterfield Missouri 63005, 1503 Lace Bark Ct. (US)
(72) HUANG, Horng-Chih, Chesterfield Missouri 63017, 1126 Nooning Tree Drive
(US)
(72) MADDUX, Todd, Kalamazoo Michigan 49009, 5856 Vista Ridge (US)
(30) US 2009 12 18 287924 P
(73) Mallinckrodt LLC, Hazelwood, MO 63042, 675 McDonnell Boulevard (US)
(54) VERFAHREN ZUR SYNTHESE VON OPIATALKALOIDEN MIT
REDUZIERTER BILDUNG VON VERUNREINIGUNGEN
(72) ORR, Brian, OFallon Missouri 63366, 1315 Presidents Landing Drive (US)
(72) STEELE, Miranda, St. Louis Missouri 63121, 5542 Horizon Drive (US)
(30) US 2008 09 30 194686 P
Österreichisches Patentblatt 111. Jahrgang Nummer 4, Seite 1177
Comentários a estes Manuais